Valeant Pharmaceuticals International Bottom Line Declines 19% In Q4
Valeant shares have risen 15 percent since the beginning of the year. (NYSE:VRX) plummeted -2.41 percent and ended the day at $16.18. The stock’s market capitalization is 5.00B, it has a 52-week low of 13.00 and a 52-week high of 86.50. Phoenix Investment Adviser LLC...
Posted On Mar 01 2017